Charles Schwab’s Sangamo Therapeutics SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$694K Buy
1,281,799
+183,965
+17% +$99.6K ﹤0.01% 3022
2025
Q1
$720K Sell
1,097,834
-41,418
-4% -$27.2K ﹤0.01% 2961
2024
Q4
$1.16M Buy
1,139,252
+35,926
+3% +$36.6K ﹤0.01% 2857
2024
Q3
$956K Buy
1,103,326
+57,125
+5% +$49.5K ﹤0.01% 2933
2024
Q2
$375K Sell
1,046,201
-195,930
-16% -$70.2K ﹤0.01% 3303
2024
Q1
$832K Buy
1,242,131
+35,252
+3% +$23.6K ﹤0.01% 2851
2023
Q4
$656K Buy
1,206,879
+15,677
+1% +$8.52K ﹤0.01% 2975
2023
Q3
$714K Buy
1,191,202
+257,676
+28% +$155K ﹤0.01% 2910
2023
Q2
$1.21M Sell
933,526
-80,248
-8% -$104K ﹤0.01% 2700
2023
Q1
$1.78M Sell
1,013,774
-618
-0.1% -$1.09K ﹤0.01% 2554
2022
Q4
$3.19M Buy
1,014,392
+74,218
+8% +$233K ﹤0.01% 2413
2022
Q3
$4.61M Buy
940,174
+63,290
+7% +$310K ﹤0.01% 2252
2022
Q2
$3.63M Sell
876,884
-6,030
-0.7% -$25K ﹤0.01% 2327
2022
Q1
$5.13M Buy
882,914
+33,270
+4% +$193K ﹤0.01% 2265
2021
Q4
$6.37M Sell
849,644
-89,690
-10% -$673K ﹤0.01% 2228
2021
Q3
$8.46M Buy
939,334
+26,340
+3% +$237K ﹤0.01% 2103
2021
Q2
$10.9M Buy
912,994
+24,290
+3% +$291K ﹤0.01% 1950
2021
Q1
$11.1M Buy
888,704
+38,616
+5% +$484K ﹤0.01% 1899
2020
Q4
$13.3M Buy
850,088
+74,035
+10% +$1.16M 0.01% 1681
2020
Q3
$7.33M Sell
776,053
-354
-0% -$3.35K ﹤0.01% 1868
2020
Q2
$6.96M Buy
776,407
+48,917
+7% +$438K ﹤0.01% 1864
2020
Q1
$4.64M Buy
727,490
+10,181
+1% +$64.9K ﹤0.01% 1874
2019
Q4
$6M Buy
717,309
+20,217
+3% +$169K ﹤0.01% 1930
2019
Q3
$6.31M Buy
697,092
+20,536
+3% +$186K ﹤0.01% 1855
2019
Q2
$7.29M Buy
676,556
+86,660
+15% +$933K ﹤0.01% 1784
2019
Q1
$5.63M Buy
589,896
+24,025
+4% +$229K ﹤0.01% 1926
2018
Q4
$6.5M Sell
565,871
-23,428
-4% -$269K 0.01% 1742
2018
Q3
$9.99M Buy
589,299
+23,698
+4% +$402K 0.01% 1643
2018
Q2
$8.03M Buy
565,601
+71,134
+14% +$1.01M 0.01% 1738
2018
Q1
$9.4M Buy
494,467
+60,750
+14% +$1.15M 0.01% 1531
2017
Q4
$7.11M Buy
433,717
+51,801
+14% +$850K 0.01% 1707
2017
Q3
$5.73M Buy
381,916
+114,623
+43% +$1.72M 0.01% 1808
2017
Q2
$2.35M Buy
267,293
+1,558
+0.6% +$13.7K ﹤0.01% 2166
2017
Q1
$1.38M Buy
265,735
+14,022
+6% +$72.9K ﹤0.01% 2322
2016
Q4
$768K Buy
251,713
+12,628
+5% +$38.5K ﹤0.01% 2509
2016
Q3
$1.11M Sell
239,085
-25,762
-10% -$119K ﹤0.01% 2381
2016
Q2
$1.53M Buy
264,847
+5,166
+2% +$29.9K ﹤0.01% 2185
2016
Q1
$1.57M Buy
259,681
+5,681
+2% +$34.4K ﹤0.01% 2169
2015
Q4
$2.32M Buy
254,000
+52,171
+26% +$477K ﹤0.01% 2005
2015
Q3
$1.14M Sell
201,829
-14,320
-7% -$80.8K ﹤0.01% 2341
2015
Q2
$2.4M Sell
216,149
-111,560
-34% -$1.24M ﹤0.01% 1985
2015
Q1
$5.14M Sell
327,709
-3,325
-1% -$52.1K 0.01% 1497
2014
Q4
$5.04M Buy
331,034
+30,000
+10% +$456K 0.01% 1443
2014
Q3
$3.25M Buy
301,034
+111,606
+59% +$1.2M 0.01% 1684
2014
Q2
$2.89M Buy
189,428
+17,296
+10% +$264K ﹤0.01% 1765
2014
Q1
$3.11M Buy
172,132
+10,012
+6% +$181K 0.01% 1682
2013
Q4
$2.25M Buy
162,120
+23,200
+17% +$322K ﹤0.01% 1845
2013
Q3
$1.67M Buy
138,920
+14,414
+12% +$173K ﹤0.01% 1960
2013
Q2
$993K Buy
+124,506
New +$993K ﹤0.01% 2163